PDT Partners LLC trimmed its holdings in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 22.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,675 shares of the scientific and technical instruments company's stock after selling 9,119 shares during the quarter. PDT Partners LLC owned 0.07% of Itron worth $3,318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ITRI. Wayfinding Financial LLC purchased a new position in Itron during the 1st quarter worth $45,000. CoreCap Advisors LLC grew its stake in Itron by 25.5% during the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock worth $67,000 after buying an additional 125 shares during the last quarter. Quarry LP grew its stake in Itron by 155.6% during the 1st quarter. Quarry LP now owns 910 shares of the scientific and technical instruments company's stock worth $95,000 after buying an additional 554 shares during the last quarter. Contravisory Investment Management Inc. grew its stake in Itron by 98.0% during the 1st quarter. Contravisory Investment Management Inc. now owns 1,711 shares of the scientific and technical instruments company's stock worth $179,000 after buying an additional 847 shares during the last quarter. Finally, Captrust Financial Advisors grew its stake in Itron by 6.3% during the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock worth $233,000 after buying an additional 128 shares during the last quarter. 96.19% of the stock is currently owned by hedge funds and other institutional investors.
Itron Stock Performance
NASDAQ ITRI opened at $122.94 on Tuesday. The stock has a 50-day simple moving average of $130.20 and a two-hundred day simple moving average of $116.24. The firm has a market capitalization of $5.62 billion, a P/E ratio of 21.02, a PEG ratio of 0.67 and a beta of 1.46. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04.
Itron (NASDAQ:ITRI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.29. The business had revenue of $606.76 million during the quarter, compared to analyst estimates of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company's revenue was down .4% on a year-over-year basis. During the same quarter last year, the business posted $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, equities analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.
Insider Buying and Selling at Itron
In related news, SVP Justin K. Patrick sold 9,036 shares of Itron stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $121.77, for a total value of $1,100,313.72. Following the completion of the transaction, the senior vice president owned 21,149 shares in the company, valued at $2,575,313.73. The trade was a 29.94% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP John F. Marcolini sold 565 shares of Itron stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $70,800.15. Following the completion of the transaction, the senior vice president owned 14,396 shares of the company's stock, valued at approximately $1,803,962.76. This represents a 3.78% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,073 shares of company stock worth $1,480,880. Insiders own 1.51% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on ITRI shares. Roth Capital boosted their target price on Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a research note on Tuesday, July 22nd. JPMorgan Chase & Co. upgraded Itron from a "neutral" rating to an "overweight" rating and raised their target price for the stock from $128.00 to $145.00 in a research note on Thursday, July 31st. Piper Sandler reduced their target price on Itron from $124.00 to $121.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Stephens set a $130.00 target price on Itron in a research note on Monday, August 4th. Finally, Guggenheim restated a "buy" rating and issued a $155.00 target price (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Eleven analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Itron has a consensus rating of "Moderate Buy" and an average target price of $136.25.
Check Out Our Latest Stock Report on ITRI
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Further Reading
Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.